During the past decade, Stroobants Cardiovascular Center conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 7 clinical trials were completed, i.e. on average, 63.6% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 7 clinical trials were completed. i.e. 350% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Stroobants Cardiovascular Center" #1 sponsor was "Medtronic Cardiac Rhythm and Heart Failure" with 2 trials, followed by "American Regent, Inc." with 1 trials sponsored, "Amgen" with 1 trials sponsored, "Baim Institute for Clinical Research" with 1 trials sponsored and "Boston Scientific Corporation" with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Stroobants Cardiovascular Center" #1 collaborator was "Duke Clinical Research Institute" with 2 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 2 trials as a collaborator, "Albany Stratton VA Medical Center" with 1 trials as a collaborator, "American College of Cardiology" with 1 trials as a collaborator and "Biosense Webster, Inc." with 1 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "Stroobants Cardiovascular Center" are "Heart Failure" (3 trials), "ASCVD" (1 trials), "Acute Myocardial Infarction" (1 trials), "Cardiovascular Diseases" (1 trials) and "Coronary Artery Disease" (1 trials). Many other conditions were trialed in "Stroobants Cardiovascular Center" in a lesser frequency.

Most popular intervention types in "Stroobants Cardiovascular Center" are "Device" (6 trials), "Drug" (4 trials), "Behavioral" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Catheter ablation" (1 trials), "EMBLEM S-ICD System" (1 trials), "Eleclazine" (1 trials) and "Etripamil" (1 trials). Other intervention names were less common.

The vast majority of trials in "Stroobants Cardiovascular Center" are 13 trials for "All" genders.

Currently, there are NaN active trials in "Stroobants Cardiovascular Center". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Stroobants Cardiovascular Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Stroobants Cardiovascular Center, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".